Michelle H Nelson

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 5

Top Topics

Intellectual Disability

Cell Cycle Arrest

Binding Protein

Top Venues

Science advances

Cancer research

Nature communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Michelle H Nelson, Sara Fritzell, Robert Miller, Doreen Werchau, Danielle Van Citters, Anneli Nilsson, Lynda Misher, Lill Ljung, Robert Bader, Adnan Deronic, Allison G Chunyk, Lena Schultz, Laura A Varas, Nadia Rose, Maria Håkansson, Jane Gross, Christina Furebring, Peter Pavlik, Anette Sundstedt, Niina Veitonmäki, Hilario J Ramos, Anna Säll, Anna Dahlman, David Bienvenue, Laura von Schantz, Catherine J McMahan, Maria Askmyr, Gabriela Hernandez-Hoyos, Peter Ellmark
The bispecific tumor antigen-conditional 4-1BB x 5T4 agonist, ALG.APV-527, mediates strong T cell activation and potent anti-tumor activity in preclinical studies. Molecular cancer therapeutics (2022)
Ephraim A Ansa-Addo, Huai-Cheng Huang, Brian Riesenberg, Supinya Iamsawat, Davis M Borucki, Michelle H Nelson, Jin Hyun Nam, Dongjun Chung, Chrystal M Paulos, Bei Liu, Xue-Zhong Yu, Caroline Philpott, Philip H Howe, Zihai Li
RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity. Science advances 6 (22) (2020)
Hannah M Knochelmann, Connor J Dwyer, Aubrey S Smith, Jacob S Bowers, Megan M Wyatt, Michelle H Nelson, Guillermo O Rangel Rivera, Joshua D Horton, Carsten Krieg, Kent Armeson, Gregory B Lesinski, Mark P Rubinstein, Zihai Li, Chrystal M Paulos
IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to Tumors. Cancer research 80 (18) (2020)
Michelle H Nelson, Hannah M Knochelmann, Stefanie R Bailey, Logan W Huff, Jacob S Bowers, Kinga Majchrzak-Kuligowska, Megan M Wyatt, Mark P Rubinstein, Shikhar Mehrotra, Michael I Nishimura, Kent E Armeson, Paul G Giresi, Michael J Zilliox, Hal E Broxmeyer, Chrystal M Paulos
Identification of human CD4+ T cell populations with distinct antitumor activity. Science advances 6 (27) (2020)
Stefanie R Bailey, Michelle H Nelson, Kinga Majchrzak, Jacob S Bowers, Megan M Wyatt, Aubrey S Smith, Lillian R Neal, Keisuke Shirai, Carmine Carpenito, Carl H June, Michael J Zilliox, Chrystal M Paulos
Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence. Nature communications 8 (1) (2017)